candesartan cilexetil and adenosine

candesartan cilexetil has been researched along with adenosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Apstein, CS; Koh, SG; Saupe, KW; Sobol, SC1
Floras, JS; Parmar, G; Rongen, GA; Wijeysundera, HC1

Trials

1 trial(s) available for candesartan cilexetil and adenosine

ArticleYear
Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure.
    European journal of heart failure, 2011, Volume: 13, Issue:5

    Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Brachial Artery; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Norepinephrine; Reflex; Regional Blood Flow; Sympathetic Nervous System; Tetrazoles; Vasodilator Agents

2011

Other Studies

2 other study(ies) available for candesartan cilexetil and adenosine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effects of AT1 receptor block begun late in life on normal cardiac aging in rats.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:4

    Topics: Adenosine; Aging; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Coronary Vessels; Exercise Tolerance; Heart; Hypertrophy, Left Ventricular; Muscle, Smooth, Vascular; Myocardium; Organ Size; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Tetrazoles; Tibia; Vascular Resistance; Vasodilation

2003